Pulmonary embolism (PE) remains the third leading cause of cardiovascular death. Although major advances in care have been made for myocardial infarction and stroke, PE has yet to experience its clinical renaissance.

Taisei Kobayashi, MD, FACC, and Jay S. Giri, MD, MPH, AACC, spoke to Cardiology magazine about how they and their colleagues published an scientific statement on interventional therapies for acute PE to consolidate and summarize current knowledge regarding existing and new therapies emerging in the field of PE management. Read more.

Follow Cardiology on Twitter using #CardiologyMag and get the full issue here.